<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Chem.</journal-id>
<journal-title>Frontiers in Chemistry</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Chem.</abbrev-journal-title>
<issn pub-type="epub">2296-2646</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1233938</article-id>
<article-id pub-id-type="doi">10.3389/fchem.2023.1233938</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Chemistry</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Nocaviogua A and B: two lipolanthines from root-nodule-associated <italic>Nocardia</italic> sp.</article-title>
<alt-title alt-title-type="left-running-head">Chang et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fchem.2023.1233938">10.3389/fchem.2023.1233938</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Chang</surname>
<given-names>Shanshan</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Luo</surname>
<given-names>Yajun</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>He</surname>
<given-names>Ning</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Huang</surname>
<given-names>Xinyue</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chen</surname>
<given-names>Mingxu</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2359478/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Yuan</surname>
<given-names>Lijie</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Xie</surname>
<given-names>Yunying</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/878139/overview"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>CAMS Key Laboratory of Synthetic Biology for Drug Innovation</institution>, <institution>Institute of Medicinal Biotechnology</institution>, <institution>Chinese Academy of Medical Sciences and Peking Union Medical College</institution>, <addr-line>Beijing</addr-line>, <country>China</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Hebei Key Laboratory for Chronic Diseases</institution>, <institution>Tangshan Key Laboratory for Preclinical and Basic Research on Chronic Diseases</institution>, <institution>School of Basic Medical Sciences</institution>, <institution>North China University of Science and Technology</institution>, <addr-line>Tangshan</addr-line>, <addr-line>Hebei</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1400189/overview">Liang Xiong</ext-link>, Chengdu University of Traditional Chinese Medicine, China</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1915336/overview">Chung Sub Kim</ext-link>, Sungkyunkwan University, Republic of Korea</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1336788/overview">Jungui Dai</ext-link>, Chinese Academy of Medical Sciences and Peking Union Medical College, China</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Lijie Yuan, <email>yuanlijie1970@163.com</email>; Yunying Xie, <email>xieyy@imb.pumc.edu.cn</email>
</corresp>
</author-notes>
<pub-date pub-type="epub">
<day>03</day>
<month>08</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="collection">
<year>2023</year>
</pub-date>
<volume>11</volume>
<elocation-id>1233938</elocation-id>
<history>
<date date-type="received">
<day>03</day>
<month>06</month>
<year>2023</year>
</date>
<date date-type="accepted">
<day>18</day>
<month>07</month>
<year>2023</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2023 Chang, Luo, He, Huang, Chen, Yuan and Xie.</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Chang, Luo, He, Huang, Chen, Yuan and Xie</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>Nocaviogua A (<bold>1</bold>) and B (<bold>2</bold>), two lipolanthines featuring a non-canonical avionin (Avi)-containing macrocycle and a long acyl chain, were identified from the mutualistic actinomycete <italic>Nocardia</italic> sp. XZ19_369, which was isolated from the nodules of sea buckthorn collected in Tibet. Their planar structures were elucidated via extensive analyses of 1D and 2D NMR, as well as HRMS data. The absolute configurations were fully elucidated by advanced Marfey&#x2019;s analysis and GIAO NMR calculations, representing the first time that the configurations of this family of lipolanthines have been determined. Nocaviogua A (<bold>1</bold>) exhibited weak cytotoxicity against human chronic uveal melanoma cells (UM92-1), non-small cell lung cancer (NCI-H2170), and breast cancer (MDA-MB-231). Our work provides valuable information on this burgeoning class of lipolanthines for further investigations.</p>
</abstract>
<kwd-group>
<kwd>lipolanthine</kwd>
<kwd>
<italic>Nocardia</italic>
</kwd>
<kwd>advanced Marfey&#x2019;s analysis</kwd>
<kwd>NMR calculations</kwd>
<kwd>cytotoxicity</kwd>
</kwd-group>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Organic Chemistry</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1">
<title>1 Introduction</title>
<p>Ribosomally synthesized and post-translationally modified peptides (RiPPs) are a large group of natural products that give rise to a potent biological activity and desirable drug-like properties, such as resistance to chemical and enzymatic degradation (<xref ref-type="bibr" rid="B20">Watrous et al., 2012</xref>; <xref ref-type="bibr" rid="B16">Montalban-Lopez et al., 2021</xref>; <xref ref-type="bibr" rid="B15">Mazo et al., 2023</xref>), conformational rigidity (<xref ref-type="bibr" rid="B2">Bobeica et al., 2020</xref>), and high target specificity (<xref ref-type="bibr" rid="B18">Ongey et al., 2017</xref>; <xref ref-type="bibr" rid="B8">Grant-Mackie et al., 2021</xref>). The structural diversity of RiPPs is multiplied by fusions with polyketides or fatty acids (<xref ref-type="bibr" rid="B12">Kozakai et al., 2020</xref>). Among them, lipolanthines are a class of polyketide/fatty acid&#x2013;ribosomally synthesized hybrid lipopeptides (PK/FA&#x2013;RiPPs) that feature a unique avionin (Avi)-containing macrocycle and a long acyl chain (<xref ref-type="bibr" rid="B21">Wiebach et al., 2018</xref>; <xref ref-type="bibr" rid="B12">Kozakai et al., 2020</xref>). Due to the utilization of class-III-type lanthipeptide synthetases in biosynthesis, these unusual natural lipopeptides were also classified as class-&#x2162; lanthipeptides (<xref ref-type="bibr" rid="B8">Grant-Mackie et al., 2021</xref>).</p>
<p>Since the first lipolanthine was reported in 2018 (<xref ref-type="bibr" rid="B21">Wiebach et al., 2018</xref>), only 12 lipolanthines, belonging to three groups (microvionin, nocavionin, and goadvionins), have been discovered, and none of their absolute configurations have been fully determined. As an emerging class of natural products, some of these lipolanthines have shown promising antibacterial effects against antibiotic-resistant bacteria, e.g., microvionin has exhibited strong antibacterial effects with MIC values of less than 0.46&#xa0;<italic>&#x3bc;</italic>g/mL against MRSA and less than 0.15&#xa0;<italic>&#x3bc;</italic>g/mL against <italic>Streptococcus pneumoniae</italic> (<xref ref-type="bibr" rid="B21">Wiebach et al., 2018</xref>); goadvionins have also been shown to inhibit the growth of Gram-positive bacteria, with goadvionin B2 displaying the MIC values of 6.4&#xa0;<italic>&#x3bc;</italic>g/mL against <italic>Staphylococcus aureus</italic>, 3.2&#xa0;<italic>&#x3bc;</italic>g/mL against <italic>B. subtilis</italic>, and 3.2&#xa0;<italic>&#x3bc;</italic>g/mL against <italic>Micrococcus luteus</italic> (<xref ref-type="bibr" rid="B12">Kozakai et al., 2020</xref>). Despite their potential, the low yield and difficulties in synthesis have hindered their pharmaceutical commercialization (<xref ref-type="bibr" rid="B15">Mazo et al., 2023</xref>).</p>
<p>In our continuing efforts to explore novel bioactive metabolites from unique habitat-derived microbes (<xref ref-type="bibr" rid="B3">Chang et al., 2022a</xref>; <xref ref-type="bibr" rid="B13">Luo et al., 2022a</xref>; <xref ref-type="bibr" rid="B4">Chang et al., 2022b</xref>; <xref ref-type="bibr" rid="B14">Luo et al., 2022b</xref>), two lipolanthines (<bold>1</bold> and <bold>2</bold>) were produced by <italic>Nocardia</italic> sp. XZ19_369, which was isolated from the nodules of sea buckthorn collected in Tibet, China. The whole structures of <bold>1</bold> and <bold>2</bold> were fully elucidated by the extensive analysis of 1D and 2D NMR data, advanced Marfey&#x2019;s method, and NMR calculations. These compounds represent the first lipolanthines with determined absolute configurations. Herein, the isolation, structural elucidation, and bioactivities of compounds <bold>1</bold> and <bold>2</bold> are described.</p>
</sec>
<sec id="s2">
<title>2 Experimental section</title>
<sec id="s2-1">
<title>2.1 General experimental procedures</title>
<p>The optical rotations were obtained using a JASCO J-815 spectrometer (JASCO International Co. Ltd., Tokyo, Japan). 1D and 2D NMR spectra were measured using a Bruker AV&#x2162;HD spectrometer (Bruker Co. Ltd., Bremen, Germany) at 600&#xa0;MHz for <sup>1</sup>H and 150&#xa0;MHz for <sup>13</sup>C in DMSO-<italic>d</italic>
<sub>6</sub> (<italic>&#x3b4;</italic>
<sub>H</sub> 2.49 and <italic>&#x3b4;</italic>
<sub>C</sub> 34.9). High-resolution mass data and advanced Marfey&#x2019;s analysis were measured using a Waters Xevo G2-XS QTof mass spectrometer (Waters Co., Manchester, United Kingdom). Column chromatography was performed on macroporous adsorption resins (Diaion 4006; Nankai Chemical Co. Ltd., China) and the CombiFlash<sup>&#xae;</sup> Rf system fitted with an ODS flash column (RediSep Rf C<sub>18</sub> flash column, 130&#xa0;g). Semi-preparative HPLC was performed using an Agilent 1200 series liquid chromatography system (quaternary pump, autosampler, and diode array detector) using a Reprosil-Pur Basic-C<sub>18</sub> column (5&#xa0;<italic>&#x3bc;</italic>m, 250 &#xd7; 10&#xa0;mm).</p>
</sec>
<sec id="s2-2">
<title>2.2 Bacterial materials</title>
<p>
<italic>Nocardia</italic> sp. XZ19_369 was isolated from the nodules of sea buckthorn collected from Tibet, China. Their draft genomes were sequenced on an Illumina HiSeq platform (Illumina, San Diego, CA, United States), assembled using SPAdes V3.13.1, and submitted to the National Center for Biotechnology Information (NCBI) database (accession no. JACVED000000000 for XZ19_369). The phylogenetic tree (<xref ref-type="sec" rid="s10">Supplementary Figure S1</xref>) was constructed using autoMLST (<xref ref-type="bibr" rid="B1">Alanjary et al., 2019</xref>).</p>
</sec>
<sec id="s2-3">
<title>2.3 Fermentation</title>
<p>
<italic>Nocardia</italic> sp. XZ19_369 grown on the ISP2 medium (0.4% glucose, 0.4% yeast extract, 1% malt extract, and 2% agar) was inoculated into 100&#xa0;mL of the ISP2 liquid medium contained in a 500-mL Erlenmeyer flask and cultured at 28&#xb0;C for 2&#xa0;days as the seed culture. For large-scale fermentation, 50&#xa0;mL of the seed culture was inoculated into 10 Erlenmeyer flasks (5&#xa0;L), each containing 1&#xa0;L of the sterile YMS medium (0.4% yeast extract, 1% malt extract and 0.4% starch soluble), and then cultivated at 28&#xb0;C for 10&#xa0;days.</p>
</sec>
<sec id="s2-4">
<title>2.4 Isolation and purification</title>
<p>The culture broth (20&#xa0;L) was centrifuged at 4,000&#xa0;rpm for 30&#xa0;min to obtain the mycelium and supernatant; the supernatant was analyzed by LC&#x2013;MS using an ACQUITY UPLC<sup>&#xae;</sup> CSH&#x2122; C<sub>18</sub> column (Waters, 1.7&#xa0;<italic>&#x3bc;</italic>m, 2.1 &#xd7; 100&#xa0;mm, at 30&#xb0;C) eluted with the gradient method (from 10% to 100% MeCN/H<sub>2</sub>O, containing 0.1% formic acid at a flow rate of 0.3&#xa0;mL/min for 10&#xa0;min) (<xref ref-type="sec" rid="s10">Supplementary Figure S2</xref>) and chromatographed over a macroporous adsorption resin column using the EtOH/H<sub>2</sub>O gradient elution (0%, 30%, 50%, 80%, and 100%; each 5&#xa0;L) to afford five corresponding fractions (Fr.1: 2350.1&#xa0;mg, Fr.2: 1576.5&#xa0;mg, Fr.3: 923.5&#xa0;mg, Fr.4: 323.6&#xa0;mg, and Fr.5: 375.2&#xa0;mg).</p>
<p>Fr.3 (923.5&#xa0;mg) was then fractionated using an ODS flash column eluted with a gradient MeCN&#x2212;H<sub>2</sub>O solution (1&#x2013;10&#xa0;min, 5%&#x2192;25% MeCN; 10&#x2013;50&#xa0;min, 25%&#x2192;50% MeCN; 50&#x2013;70&#xa0;min, 50%&#x2192;100% MeCN; 70&#x2013;80&#xa0;min, and 100% MeCN; 15&#xa0;mL/min) to yield four fractions (Fr.3&#x2013;1&#x2212;Fr.3&#x2013;4). Fr.3&#x2013;3 was further purified by reversed-phase semipreparative HPLC (Reprosil-Pur Basic-C<sub>18</sub> column; 5&#xa0;<italic>&#x3bc;</italic>m, 250 &#xd7; 10&#xa0;mm, 2.5&#xa0;mL/min, and 28% MeCN&#x2212;H<sub>2</sub>O in 0.1% trifluoroacetic acid) to yield <bold>1</bold> (5.2&#xa0;mg) and <bold>2</bold> (3.0&#xa0;mg).</p>
</sec>
<sec id="s2-5">
<title>2.5 Spectroscopic data on compounds</title>
<sec id="s2-5-1">
<title>2.5.1 Nocaviogua A (<bold>1</bold>)</title>
<p>White powder; <inline-formula id="inf1">
<mml:math id="m1">
<mml:mrow>
<mml:msubsup>
<mml:mrow>
<mml:mfenced open="[" close="]" separators="|">
<mml:mrow>
<mml:mi>&#x3b1;</mml:mi>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
<mml:mi>D</mml:mi>
<mml:mn>20</mml:mn>
</mml:msubsup>
</mml:mrow>
</mml:math>
</inline-formula>-2.00 (<italic>c</italic> 0.2, CH<sub>3</sub>OH); UV (DAD) 219&#xa0;nm and 261&#xa0;nm; <sup>1</sup>H (600&#xa0;MHz, DMSO-<italic>d</italic>
<sub>6</sub>) and <sup>13</sup>C NMR (150&#xa0;MHz, DMSO-<italic>d</italic>
<sub>6</sub>), as shown in <xref ref-type="table" rid="T1">Table 1</xref>; HRESIMS <italic>m/z</italic> [M &#x2b; H]<sup>&#x2b;</sup> 918.4514 (calcd for C<sub>41</sub>H<sub>64</sub>N<sub>11</sub>O<sub>11</sub>S, 918.4507).</p>
<table-wrap id="T1" position="float">
<label>TABLE 1</label>
<caption>
<p>
<sup>1</sup>H NMR (600&#xa0;MHz) and <sup>13</sup>C NMR (150&#xa0;MHz) data for compounds <bold>1</bold>&#x2013;<bold>2</bold> <bold>in</bold> <bold>DMSO-</bold>
<italic>
<bold>d</bold>
</italic>
<sub>
<italic>
<bold>6</bold>
</italic>
</sub>.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th colspan="2" align="center"/>
<th colspan="2" align="center">Nocaviogua A (1)</th>
<th colspan="2" align="center">Nocaviogua B (2)</th>
</tr>
<tr>
<th colspan="2" align="left">No.</th>
<th align="center">
<italic>&#x3B4;</italic>
<sub>C</sub>, type</th>
<th align="center">
<italic>&#x3B4;</italic>
<sub>H</sub>, multi. (<italic>J</italic> in Hz)</th>
<th align="center">
<italic>&#x3b4;</italic>
<sub>C</sub>, type</th>
<th align="center">
<italic>&#x3b4;</italic>
<sub>H</sub>, multi. (<italic>J</italic> in Hz)</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td rowspan="19" align="center">MGFA</td>
<td align="center">1</td>
<td align="center">165.1, C</td>
<td align="center">&#x2014;</td>
<td align="center">165.5, C</td>
<td align="center">&#x2014;</td>
</tr>
<tr>
<td align="center">2</td>
<td align="center">122.9, CH</td>
<td align="center">5.99, d (15.6)</td>
<td align="center">122.7, CH</td>
<td align="center">5.98, d (15.0)</td>
</tr>
<tr>
<td align="center">3</td>
<td align="center">139.6, CH</td>
<td align="center">7.07, dd (11.4, 15.0)</td>
<td align="center">139.9, CH</td>
<td align="center">6.96, dd (11.4, 15.0)</td>
</tr>
<tr>
<td align="center">4</td>
<td align="center">128.7, CH</td>
<td align="center">6.19, dd (11.4, 15.0)</td>
<td align="center">128.7, CH</td>
<td align="center">6.20, dd (11.4, 15.0)</td>
</tr>
<tr>
<td align="center">5</td>
<td align="center">141.4, CH</td>
<td align="center">6.05, dt (7.2, 15.0)</td>
<td align="center">141.6, CH</td>
<td align="center">6.04, dt (6.6, 15.0)</td>
</tr>
<tr>
<td align="center">6</td>
<td align="center">32.3, CH<sub>2</sub>
</td>
<td align="center">2.17, m</td>
<td align="center">32.3, CH<sub>2</sub>
</td>
<td align="center">2.18, m</td>
</tr>
<tr>
<td align="center">7</td>
<td align="center">31.4, CH<sub>2</sub>
</td>
<td align="center">2.07, m</td>
<td align="center">31.4, CH<sub>2</sub>
</td>
<td align="center">2.07, dt (7.2, 13.2)</td>
</tr>
<tr>
<td align="center">8</td>
<td align="center">129.3, CH</td>
<td align="center">5.40, dd (5.4, 15.0)</td>
<td align="center">129.4, CH</td>
<td align="center">5.38, dd (5.4, 15.6)</td>
</tr>
<tr>
<td align="center">9</td>
<td align="center">130.4, CH</td>
<td align="center">5.40, dd (5.4, 15.0)</td>
<td align="center">130.4, CH</td>
<td align="center">5.42, dd (5.4, 15.6)</td>
</tr>
<tr>
<td align="center">10</td>
<td align="center">31.5, CH<sub>2</sub>
</td>
<td align="center">1.96, m</td>
<td align="center">31.6, CH<sub>2</sub>
</td>
<td align="center">1.95, dt (7.2, 12.6)</td>
</tr>
<tr>
<td align="center">11</td>
<td align="center">26.0, CH<sub>2</sub>
</td>
<td align="center">1.31, m</td>
<td align="center">26.0, CH<sub>2</sub>
</td>
<td align="center">1.30, m</td>
</tr>
<tr>
<td align="center">12</td>
<td align="center">28.0, CH<sub>2</sub>
</td>
<td align="center">1.46, m</td>
<td align="center">28.0, CH<sub>2</sub>
</td>
<td align="center">1.46, m</td>
</tr>
<tr>
<td align="center">13</td>
<td align="center">40.8, CH<sub>2</sub>
</td>
<td align="center">3.08, m</td>
<td align="center">40.8, CH<sub>2</sub>
</td>
<td align="center">3.08, m</td>
</tr>
<tr>
<td align="center">14</td>
<td align="center">155.2, C</td>
<td align="center">&#x2014;</td>
<td align="center">155.2, C</td>
<td align="center">&#x2014;</td>
</tr>
<tr>
<td align="center">15</td>
<td align="center">28.0, CH<sub>3</sub>
</td>
<td align="center">2.72, d (5.4)</td>
<td align="center">28.0, CH<sub>3</sub>
</td>
<td align="center">2.72, d (4.8)</td>
</tr>
<tr>
<td align="center">16</td>
<td align="center">28.0, CH<sub>3</sub>
</td>
<td align="center">2.72, d (5.4)</td>
<td align="center">28.0, CH<sub>3</sub>
</td>
<td align="center">2.72, d (4.8)</td>
</tr>
<tr>
<td align="center">13-NH</td>
<td align="center">&#x2014;</td>
<td align="center">7.32, t (6.0)</td>
<td align="center">&#x2014;</td>
<td align="center">7.33, m</td>
</tr>
<tr>
<td align="center">15-NH</td>
<td align="center">&#x2014;</td>
<td align="center">7.41, q (5.4)</td>
<td align="center">&#x2014;</td>
<td align="center">7.43, q (4.8)</td>
</tr>
<tr>
<td align="center">16-NH</td>
<td align="center">&#x2014;</td>
<td align="center">7.41, q (5.4)</td>
<td align="center">&#x2014;</td>
<td align="center">7.43, q (4.8)</td>
</tr>
<tr>
<td rowspan="4" align="center">Ala<sub>1</sub>
</td>
<td align="center">1</td>
<td align="center">171.5, C</td>
<td align="center">&#x2014;</td>
<td align="center">172.3, C</td>
<td align="center">&#x2014;</td>
</tr>
<tr>
<td align="center">2</td>
<td align="center">48.6, CH</td>
<td align="center">4.20, m</td>
<td align="center">48.7, CH</td>
<td align="center">4.24, m</td>
</tr>
<tr>
<td align="center">3</td>
<td align="center">17.6, CH<sub>3</sub>
</td>
<td align="center">1.16, d (7.2)</td>
<td align="center">17.3, CH<sub>3</sub>
</td>
<td align="center">1.20, d (7.2)</td>
</tr>
<tr>
<td align="center">2-NH</td>
<td align="center">&#x2014;</td>
<td align="center">8.06, d (6.6)</td>
<td align="center">&#x2014;</td>
<td align="center">8.29, d (6.6)</td>
</tr>
<tr>
<td rowspan="5" align="center">Avi<sub>2</sub>
</td>
<td align="center">1</td>
<td align="center">171.2, C</td>
<td align="center">&#x2014;</td>
<td align="center">171.6, C</td>
<td align="center">&#x2014;</td>
</tr>
<tr>
<td align="center">2</td>
<td align="center">52.2, CH</td>
<td align="center">4.17, m</td>
<td align="center">49.7, CH</td>
<td align="center">4.27, m</td>
</tr>
<tr>
<td rowspan="2" align="center">3</td>
<td rowspan="2" align="center">34.7, CH<sub>2</sub>
</td>
<td align="center">3.01, t (13.8)</td>
<td rowspan="2" align="center">34.3, CH<sub>2</sub>
</td>
<td align="center">2.27, m</td>
</tr>
<tr>
<td align="center">2.11, dd (5.4, 13.8)</td>
<td align="center">2.50, m</td>
</tr>
<tr>
<td align="center">2-NH</td>
<td align="center">&#x2014;</td>
<td align="center">7.91, d (7.8)</td>
<td align="center">&#x2014;</td>
<td align="center">8.15, d (8.4)</td>
</tr>
<tr>
<td rowspan="6" align="center">Val<sub>3</sub>
</td>
<td align="center">1</td>
<td align="center">171.3, C</td>
<td align="center">&#x2014;</td>
<td align="center">172.7, C</td>
<td align="center">&#x2014;</td>
</tr>
<tr>
<td align="center">2</td>
<td align="center">53.4, CH</td>
<td align="center">4.16, m</td>
<td align="center">57.6, CH</td>
<td align="center">4.06, dd (6.6, 8.4)</td>
</tr>
<tr>
<td align="center">3</td>
<td align="center">28.8, CH</td>
<td align="center">1.97, m</td>
<td align="center">29.8, CH</td>
<td align="center">2.06, m</td>
</tr>
<tr>
<td align="center">4</td>
<td align="center">20.2, CH<sub>3</sub>
</td>
<td align="center">0.74, d (6.0)</td>
<td align="center">18.3, CH<sub>3</sub>
</td>
<td align="center">0.78, d (7.2)</td>
</tr>
<tr>
<td align="center">5</td>
<td align="center">17.8, CH<sub>3</sub>
</td>
<td align="center">0.60, d (6.6)</td>
<td align="center">17.3, CH<sub>3</sub>
</td>
<td align="center">0.84, d (7.2)</td>
</tr>
<tr>
<td align="center">2-NH</td>
<td align="center">&#x2014;</td>
<td align="center">7.49, m</td>
<td align="center">&#x2014;</td>
<td align="center">7.66, d (8.4)</td>
</tr>
<tr>
<td rowspan="7" align="center">Ser<sub>4</sub>
</td>
<td align="center">1</td>
<td align="center">170.3, C</td>
<td align="center">&#x2014;</td>
<td align="center">166.4, C</td>
<td align="center">&#x2014;</td>
</tr>
<tr>
<td align="center">2</td>
<td align="center">58.4, CH</td>
<td align="center">3.84, m</td>
<td align="center">55.0, CH</td>
<td align="center">3.86, m</td>
</tr>
<tr>
<td rowspan="2" align="center">3</td>
<td rowspan="2" align="center">61.4, CH<sub>2</sub>
</td>
<td rowspan="2" align="center">3.50, m</td>
<td rowspan="2" align="center">59.8, CH<sub>2</sub>
</td>
<td align="center">3.69, m</td>
</tr>
<tr>
<td align="center">3.82, m</td>
</tr>
<tr>
<td align="center">3-OH</td>
<td align="center">&#x2014;</td>
<td align="center">&#x2014;</td>
<td align="center">&#x2014;</td>
<td align="center">5.65, s</td>
</tr>
<tr>
<td align="center">2-NH</td>
<td align="center">&#x2014;</td>
<td align="center">7.40, m</td>
<td align="center">&#x2014;</td>
<td align="center">&#x2014;</td>
</tr>
<tr>
<td align="center">2-NH<sub>2</sub>
</td>
<td align="center">&#x2014;</td>
<td align="center">&#x2014;</td>
<td align="center">&#x2014;</td>
<td align="center">8.11, d (5.4)</td>
</tr>
<tr>
<td rowspan="5" align="center">Avi<sub>5</sub>
</td>
<td align="center">1</td>
<td align="center">169.1, C</td>
<td align="center">&#x2014;</td>
<td align="center">169.8, C</td>
<td align="center">&#x2014;</td>
</tr>
<tr>
<td align="center">2</td>
<td align="center">60.9, C</td>
<td align="center">&#x2014;</td>
<td align="center">62.0, C</td>
<td align="center">&#x2014;</td>
</tr>
<tr>
<td rowspan="2" align="center">3</td>
<td rowspan="2" align="center">41.0, CH<sub>2</sub>
</td>
<td align="center">3.86, d (10.2)</td>
<td rowspan="2" align="center">41.6, CH<sub>2</sub>
</td>
<td align="center">2.07, m</td>
</tr>
<tr>
<td align="center">2.74, d (10.2)</td>
<td align="center">1.96, m</td>
</tr>
<tr>
<td align="center">2-NH</td>
<td align="center">&#x2014;</td>
<td align="center">6.83, s</td>
<td align="center">&#x2014;</td>
<td align="center">8.60, s</td>
</tr>
<tr>
<td rowspan="8" align="center">Asn<sub>6</sub> or Asp<sub>6</sub>
</td>
<td align="center">1</td>
<td align="center">170.3, C</td>
<td align="center">&#x2014;</td>
<td align="center">171.4, C</td>
<td align="center">&#x2014;</td>
</tr>
<tr>
<td align="center">2</td>
<td align="center">49.6, CH</td>
<td align="center">4.84, dt (3.0, 7.2)</td>
<td align="center">49.7, CH</td>
<td align="center">4.71, m</td>
</tr>
<tr>
<td rowspan="2" align="center">3</td>
<td rowspan="2" align="center">36.0, CH<sub>2</sub>
</td>
<td align="center">2.75, m</td>
<td rowspan="2" align="center">35.8, CH<sub>2</sub>
</td>
<td align="center">2.25, m</td>
</tr>
<tr>
<td align="center">2.88, dd (3.0, 16.2)</td>
<td align="center">2.76, m</td>
</tr>
<tr>
<td align="center">4</td>
<td align="center">172.4, C</td>
<td align="center">&#x2014;</td>
<td align="center">171.54, C</td>
<td align="center">&#x2014;</td>
</tr>
<tr>
<td rowspan="2" align="center">4-NH<sub>2</sub>
</td>
<td rowspan="2" align="center">&#x2014;</td>
<td rowspan="2" align="center">&#x2014;</td>
<td rowspan="2" align="center">&#x2014;</td>
<td align="center">7.33, s</td>
</tr>
<tr>
<td align="center">6.89, s</td>
</tr>
<tr>
<td align="center">2-NH</td>
<td align="center">&#x2014;</td>
<td align="center">8.50, d (7.2)</td>
<td align="center">&#x2014;</td>
<td align="center">8.20, d (8.4)</td>
</tr>
<tr>
<td rowspan="4" align="center">Gly<sub>7</sub>
</td>
<td align="center">1</td>
<td align="center">167.6, C</td>
<td align="center">&#x2014;</td>
<td align="center">167.0, C</td>
<td align="center">&#x2014;</td>
</tr>
<tr>
<td rowspan="2" align="center">2</td>
<td rowspan="2" align="center">43.6, CH<sub>2</sub>
</td>
<td align="center">3.49, m</td>
<td rowspan="2" align="center">43.0, CH<sub>2</sub>
</td>
<td align="center">3.53, m</td>
</tr>
<tr>
<td align="center">4.07, dd (6.0, 16.8)</td>
<td align="center">3.94, m</td>
</tr>
<tr>
<td align="center">2-NH</td>
<td align="center">&#x2014;</td>
<td align="center">8.82, t (6.0)</td>
<td align="center">&#x2014;</td>
<td align="center">8.81, t (6.0)</td>
</tr>
<tr>
<td rowspan="3" align="center">Avi<sub>8</sub>
</td>
<td align="center">1</td>
<td align="center">98.7, CH</td>
<td align="center">5.28, d (7.2)</td>
<td align="center">99.3, CH</td>
<td align="center">5.40, d (7.2)</td>
</tr>
<tr>
<td align="center">2</td>
<td align="center">132.8, CH</td>
<td align="center">7.16, dd (7.2, 11.4)</td>
<td align="center">132.8, CH</td>
<td align="center">7.19, dd (7.2, 11.4)</td>
</tr>
<tr>
<td align="center">2-NH</td>
<td align="center">&#x2014;</td>
<td align="center">8.95, d (11.4)</td>
<td align="center">&#x2014;</td>
<td align="center">8.73, d (11.4)</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s2-5-2">
<title>2.5.2 Nocaviogua B (<bold>2</bold>)</title>
<p>White powder; <inline-formula id="inf2">
<mml:math id="m2">
<mml:mrow>
<mml:msubsup>
<mml:mrow>
<mml:mfenced open="[" close="]" separators="|">
<mml:mrow>
<mml:mi>&#x3b1;</mml:mi>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
<mml:mi>D</mml:mi>
<mml:mn>20</mml:mn>
</mml:msubsup>
</mml:mrow>
</mml:math>
</inline-formula>-2.96 (<italic>c</italic> 0.3, CH<sub>3</sub>OH); UV (DAD) 219&#xa0;nm and 261&#xa0;nm; <sup>1</sup>H (600&#xa0;MHz, DMSO-<italic>d</italic>
<sub>6</sub>) and <sup>13</sup>C NMR (150&#xa0;MHz, DMSO-<italic>d</italic>
<sub>6</sub>), as shown in <xref ref-type="table" rid="T1">Table 1</xref>; HRESIMS <italic>m/z</italic> [M &#x2b; H]<sup>&#x2b;</sup> 935.4766 (calcd for C<sub>41</sub>H<sub>67</sub>N<sub>12</sub>O<sub>11</sub>S, 935.4773).</p>
</sec>
</sec>
<sec id="s2-6">
<title>2.6 Advanced Marfey&#x2019;s method</title>
<p>Each compound <bold>1</bold>&#x2013;<bold>2</bold> (50&#xa0;<italic>&#x3bc;</italic>g) was dissolved in a 100&#xa0;<italic>&#x3bc;</italic>L of 6&#xa0;N HCl and heated at 110&#xb0;C for 24&#xa0;h. After heating, the hydrolysates were divided into two parts and dried under the N<sub>2</sub> flow. The dried hydrolysates and each standard amino acid (<italic>L</italic>-Ala, <italic>L</italic>-Val, <italic>L</italic>-Ser, and <italic>L</italic>-Asp) were dissolved in 30&#xa0;<italic>&#x3bc;</italic>L of the 0.1&#xa0;M NaHCO<sub>3</sub> solution. To each reaction vial, 30&#xa0;<italic>&#x3bc;</italic>L of <italic>L</italic>-FDAA (<italic>N</italic>
<sub>&#x3b1;</sub>-(2,4-dinitro-5-fluorophenyl)-<italic>L</italic>-alaninamide, 1% solution in acetone) was added and heated at 40&#xb0;C for 1&#xa0;h (<xref ref-type="bibr" rid="B11">Kiyonaga Fujii, 1997a</xref>; <xref ref-type="bibr" rid="B10">Kiyonaga Fujii, 1997b</xref>). After cooling at room temperature, 30&#xa0;<italic>&#x3bc;</italic>L of 0.1&#xa0;M HCl was added to each vial. The mixtures were diluted with 500&#xa0;<italic>&#x3bc;</italic>L of MeOH. The other part of hydrolysates and standard amino acids were derived with <italic>D</italic>-FDAA in the same manner. The aforementioned derivatives were analyzed with LC&#x2013;MS using an ACQUITY UPLC<sup>&#xae;</sup> CSH&#x2122; C<sub>18</sub> column (Waters, 1.7&#xa0;<italic>&#x3bc;</italic>m, 2.1 &#xd7; 100&#xa0;mm, at 30&#xb0;C) eluted with the gradient method (from 15% to 60% MeCN/H<sub>2</sub>O with a 5% isocratic MeOH containing 1% formic acid at a flow rate of 0.3&#xa0;mL/min for 30&#xa0;min) and isocratic elution method (from 12% MeCN/H<sub>2</sub>O with a 5% isocratic MeOH containing 1% formic acid at a flow rate of 0.3&#xa0;mL/min for 30&#xa0;min). The configurations of amino acids were confirmed by comparison with the authentic standards. The <italic>L</italic>-FDAA/<italic>D</italic>-FDAA derivatized authentic amino acids provided retention times (<italic>t</italic>
<sub>R</sub>, min): <italic>L</italic>-Ala-<italic>L</italic>-FDAA and <italic>L</italic>-Ala-<italic>D</italic>-FDAA (7.80 and 9.22&#xa0;min, <italic>m/z</italic> 342), <italic>L</italic>-Val-<italic>L</italic>-FDAA and <italic>L</italic>-Val-<italic>D</italic>-FDAA (11.52 and 14.18&#xa0;min, <italic>m/z</italic> 370), <italic>L</italic>-Asp-<italic>L</italic>-FDAA and <italic>L</italic>-Asp-<italic>D</italic>-FDAA (6.22 and 6.76&#xa0;min, <italic>m/z</italic> 386), and <italic>L</italic>-Ser-<italic>L</italic>-FDAA and <italic>L</italic>-Ser-<italic>D</italic>-FDAA (9.99 and 11.32&#xa0;min, <italic>m/z</italic> 358). The presence of Ala, Val, Asp (Asn), and Ser residues in <bold>1</bold> and <bold>2</bold> was also assigned to the <italic>L</italic>-configuration.</p>
</sec>
<sec id="s2-7">
<title>2.7 NMR calculations</title>
<p>In order to simplify the calculation, the bismethylated guanidino fatty acid (MGFA) was replaced with acetic acid, which was not impacted with the accuracy of the result (<xref ref-type="bibr" rid="B6">Daranas and Sarotti, 2021</xref>). Conformational analysis was performed using OpenBabel (<xref ref-type="bibr" rid="B17">O&#x27;Boyle et al., 2011</xref>) with a genetic algorithm at the MMFF94 force field, with energies within the 3.0&#xa0;kcal/mol energy threshold (<xref ref-type="bibr" rid="B19">Spartan14. Wavefunction, 2019</xref>). The conformers were optimized using Gaussian 16 (Gaussian Inc.) (M. J. <xref ref-type="bibr" rid="B7">Frisch, 2010</xref>) at the M062X/6-311&#x2b;G (d, p) level in vacuum. At the same level, the frequencies were calculated to provide the relative thermal free energies (&#x394;G), which are used to calculate the equilibrium populations. NMR chemical shift calculations for those optimized conformers within their Boltzmann distribution (&#x3e;1%) were performed using the GIAO method at the mPW1PW91/6-311&#x2b;G (d, p) level in DMSO with the PCM model. The calculated chemical shifts of conformers for <bold>1</bold>&#x2013;<bold>2</bold> were averaged in terms of their relative Gibbs free energy and the Boltzmann distribution theory. Finally, the calculated NMR chemical shift values were averaged according to Boltzmann distribution for each conformer and fit to the experimental values by linear regression. DP4&#x2b; probability analysis was performed according to the reported methods (<xref ref-type="bibr" rid="B9">Grimblat et al., 2015</xref>).</p>
</sec>
<sec id="s2-8">
<title>2.8 Antibacterial assays</title>
<p>Antibacterial assays were conducted in flat bottom, sterile 96-well plates (Corning, America) in triplicate, using a broth microdilution protocol (<xref ref-type="bibr" rid="B5">Cockerill, 2012</xref>). <italic>Candida albicans</italic> (ATCC 10231), <italic>Staphylococcus aureus</italic> (ATCC 29213), <italic>Enterococcus faecium</italic> (ATCC 35667), <italic>Candida tropicalis</italic> (ATCC 1369), <italic>Escherichia coli</italic> (ATCC 25922), <italic>Klebsiella pneumoniae</italic> (ATCC 700603), and <italic>Pseudomonas aeruginosa</italic> (ATCC 27853) were used as test strains. Each bacterial culture (100&#xa0;<italic>&#x3bc;</italic>L) containing ca. 5 &#xd7; 10<sup>4</sup>&#xa0;CFU was added to each well of 96-well plates. Nocaviogua A and B (<bold>1</bold> and <bold>2</bold>) were dissolved in DMSO. A measure of 1&#xa0;<italic>&#x3bc;</italic>L of each work solution of compounds <bold>1</bold>&#x2013;<bold>2</bold> and the corresponding positive drugs (1.28&#x2013;0.00125&#xa0;mg/mL) were added to each well and incubated at 30&#xb0;C for 24&#xa0;h for determining MIC values.</p>
</sec>
<sec id="s2-9">
<title>2.9 Cytotoxic activity assays</title>
<p>The cytotoxic effects of compounds <bold>1</bold>&#x2013;<bold>2</bold> were evaluated against uveal melanoma cells 92-1 (UM92-1), non-small cell lung cancer (NCI-H2170), and three breast cancer cell lines (SK-BR-3, MDA-MB-231, and MDA-MB-453) by the 3-(4, 5-dimethyl-2-thiazolyl)-2, 5-diphenyl-2H tetrazolium bromide (MTT) method. After cells (ca. 3&#xd7;10<sup>3</sup>&#xa0;cells/200&#xa0;<italic>&#x3bc;</italic>L/well) were seeded in a 96-well plate and cultured in a 5% CO<sub>2</sub> incubator at 37&#xb0;C for 24&#xa0;h, <bold>1</bold> and <bold>2</bold> were added to each well for 48&#xa0;h incubation. Then, the medium was removed, and the MTT solution was subsequently added to each well and maintained for 4&#xa0;h. After removing the supernatant, 150&#xa0;<italic>&#x3bc;</italic>L DMSO was added to dissolve purple crystals. Ultimately, the absorbance value was read at 570&#xa0;nm using a microplate reader (Elx800, BioTek Instruments, Inc., United States). The assays were performed four times, and bleomycin was used as the positive control.</p>
</sec>
</sec>
<sec sec-type="results|discussion" id="s3">
<title>3 Results and discussions</title>
<sec id="s3-1">
<title>3.1 Structure elucidation</title>
<p>Nocaviogua A (<bold>1</bold>) was purified as white amorphous powder. HRESIMS of <bold>1</bold> disclosed a molecular formula of C<sub>41</sub>H<sub>64</sub>N<sub>11</sub>O<sub>11</sub>S using a quasi-molecular ion at <italic>m/z</italic> 918.4514 {[M &#x2b; H]<sup>&#x2b;</sup>, calcd 918.4507, with 16 double-bond equivalents (DBEs)}. The <sup>1</sup>H NMR and <sup>13</sup>C NMR data (<xref ref-type="table" rid="T1">Table 1</xref>) recorded in DMSO-<italic>d</italic>
<sub>6</sub> revealed nine amide and/or ester carbonyl carbons (<italic>&#x3b4;</italic>
<sub>C</sub> 165.1&#x2013;172.4), nine alkenyl carbons (<italic>&#x3b4;</italic>
<sub>C</sub> 98.7&#x2013;155.2 and <italic>&#x3b4;</italic>
<sub>H</sub> 7.16&#x2013;5.28), and eleven NH (<italic>&#x3b4;</italic>
<sub>H</sub> 6.83&#x2013;8.95), accounting for 14 DBEs and requiring that <bold>1</bold> incorporates two rings. The existence of one alanine (Ala) moiety in <bold>1</bold> was confirmed due to the presence of the spin system NH-CH-CH<sub>3</sub> revealed by the <sup>1</sup>H-<sup>1</sup>H COSY sequential correlations, together with the HMBC correlations from Ala<sub>1</sub>-2 (<italic>&#x3b4;</italic>
<sub>H</sub> 4.20) and Ala<sub>1</sub>-3 (<italic>&#x3b4;</italic>
<sub>H</sub> 1.16) to Ala<sub>1</sub>-CO (<italic>&#x3b4;</italic>
<sub>C</sub> 171.5). One valine (Val) unit in <bold>1</bold> was inferred by the presence of a spin system of -NH-CH-CH(CH<sub>3</sub>)<sub>2</sub>, which is indicated by the <sup>1</sup>H-<sup>1</sup>H COSY correlations, and then confirmed by the HMBC correlations from Val<sub>3</sub>-2 (<italic>&#x3b4;</italic>
<sub>H</sub> 4.16) and Val<sub>3</sub>-3 (<italic>&#x3b4;</italic>
<sub>H</sub> 1.97) to Val<sub>3</sub>-CO (<italic>&#x3b4;</italic>
<sub>C</sub> 171.3). The existence of one serine (Ser) residue was identified based on the spin system of -NH-CH-CH<sub>2</sub> deduced from <sup>1</sup>H-<sup>1</sup>H COSY correlations, as well as the key HMBC correlations from Ser<sub>4</sub>-2 (<italic>&#x3b4;</italic>
<sub>H</sub> 3.84) and Ser<sub>4</sub>-3 (<italic>&#x3b4;</italic>
<sub>H</sub> 3.50) to Ser<sub>4</sub>-CO (<italic>&#x3b4;</italic>
<sub>C</sub> 170.3) (<xref ref-type="fig" rid="F1">Figure 1</xref>). One asparagine (Asn) or aspartic acid (Asp) moiety was inferred by the presence of the spin system of -NH-CH-CH<sub>2</sub>, which is indicated by the <sup>1</sup>H-<sup>1</sup>H COSY correlations, and then confirmed by the HMBC correlations from Asp<sub>6</sub>/Asn<sub>6</sub>-3 (<italic>&#x3b4;</italic>
<sub>H</sub> 2.75, 2.88) to Asp<sub>6</sub>/Asn<sub>6</sub>-CO<sub>1</sub> (<italic>&#x3b4;</italic>
<sub>C</sub> 170.3) and Asp<sub>6</sub>/Asn<sub>6</sub>-CO<sub>4</sub> (<italic>&#x3b4;</italic>
<sub>C</sub> 172.4), and Asp<sub>6</sub>/Asn<sub>6</sub>-2 (<italic>&#x3b4;</italic>
<sub>H</sub> 4.84) to Asp<sub>6</sub>/Asn<sub>6</sub>-CO<sub>4</sub> (<italic>&#x3b4;</italic>
<sub>C</sub> 172.4). One glycine (Gly) residue was discovered due to the presence of the spin system of -NH-CH<sub>2</sub> revealed by the <sup>1</sup>H-<sup>1</sup>H COSY correlation, together with the HMBC correlations from Gly<sub>7</sub>-2 (<italic>&#x3b4;</italic>
<sub>H</sub> 3.49, 4.07) to Gly<sub>7</sub>-CO (<italic>&#x3b4;</italic>
<sub>C</sub> 167.6). The existence of one avionin, which includes three amino acid residues, namely, Avi<sub>1</sub>, Avi<sub>2</sub>, and Avi<sub>3</sub> moieties, can be revealed by the spin system of NH-CH-CH<sub>2</sub> in Avi<sub>2</sub> and NH-CH &#x3d; CH in Avi<sub>8</sub>, together with the key HMBC correlations from Avi<sub>2</sub>-2 (<italic>&#x3b4;</italic>
<sub>H</sub> 4.17) to Avi<sub>2</sub>-CO (<italic>&#x3b4;</italic>
<sub>C</sub> 171.2), from Avi<sub>5</sub>-3 (<italic>&#x3b4;</italic>
<sub>H</sub> 2.74, 3.86) to Avi<sub>5</sub>-CO (<italic>&#x3b4;</italic>
<sub>C</sub> 169.1) and Avi<sub>5</sub>-C<sub>2</sub> (<italic>&#x3b4;</italic>
<sub>C</sub> 60.9), and from Avi<sub>5</sub>-NH (<italic>&#x3b4;</italic>
<sub>H</sub> 6.83) to Avi<sub>5</sub>-CO (<italic>&#x3b4;</italic>
<sub>C</sub> 169.1) and Avi<sub>5</sub>-C<sub>2</sub> (<italic>&#x3b4;</italic>
<sub>C</sub> 60.9). The double-bond geometry of the Avi<sub>8</sub> moiety was established as <italic>Z</italic> based on the small coupling constant (7.2&#xa0;Hz) and the ROESY correlation between Avi<sub>8</sub>-(CH)<sub>1</sub> and Avi<sub>8</sub>-(CH)<sub>2</sub>. Additionally, an N-terminal MGFA was confirmed by the spin system of -CH-CH-CH-CH-CH<sub>2</sub>-CH<sub>2</sub>-CH-CH-CH<sub>2</sub>-CH<sub>2</sub>-CH<sub>2</sub>-CH<sub>2</sub>-NH and two -NH-CH<sub>3</sub> units, and key HMBC correlations from MGFA-2 (<italic>&#x3b4;</italic>
<sub>H</sub> 5.99) to MGFA-CO (<italic>&#x3b4;</italic>
<sub>C</sub> 165.1), and from MGFA-15 (<italic>&#x3b4;</italic>
<sub>H</sub> 2.72), MGFA-16 (<italic>&#x3b4;</italic>
<sub>H</sub> 2.72), and MGFA-13-NH (<italic>&#x3b4;</italic>
<sub>H</sub> 7.32) to MGFA-C<sub>14</sub> (<italic>&#x3b4;</italic>
<sub>C</sub> 155.2). The alkenyls in MGFA were all <italic>E</italic> arrangements based on the large coupling constant (equal or greater than 15.0&#xa0;Hz).</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Key 2D NMR correlations of nocaviogua A (<bold>1</bold>) and nocaviogua B (<bold>2</bold>).</p>
</caption>
<graphic xlink:href="fchem-11-1233938-g001.tif"/>
</fig>
<p>The connection sequence of these nine groups was established by HMBC correlations from Ala<sub>1</sub>-NH (<italic>&#x3b4;</italic>
<sub>H</sub> 8.06) to MGFA-CO (<italic>&#x3b4;</italic>
<sub>C</sub> 165.1), from Avi<sub>2</sub>-NH (<italic>&#x3b4;</italic>
<sub>H</sub> 7.91) to Ala<sub>1</sub>-CO (<italic>&#x3b4;</italic>
<sub>C</sub> 171.5), from Val<sub>3</sub>-NH (<italic>&#x3b4;</italic>
<sub>H</sub> 7.49) to Avi<sub>2</sub>-CO (<italic>&#x3b4;</italic>
<sub>C</sub> 171.2), from Ser<sub>4</sub>-NH (<italic>&#x3b4;</italic>
<sub>H</sub> 7.40) to Val<sub>3</sub>-CO (<italic>&#x3b4;</italic>
<sub>C</sub> 171.3), from Avi<sub>5</sub>-NH (<italic>&#x3b4;</italic>
<sub>H</sub> 6.83) to Ser<sub>4</sub>-CO (<italic>&#x3b4;</italic>
<sub>C</sub> 170.3), from Asp<sub>6</sub>/Asn<sub>6</sub>-NH (<italic>&#x3b4;</italic>
<sub>H</sub> 8.50) to Avi<sub>5</sub>-CO (<italic>&#x3b4;</italic>
<sub>C</sub> 169.1), from Gly<sub>7</sub>-NH (<italic>&#x3b4;</italic>
<sub>H</sub> 8.82) to Asp<sub>6</sub>/Asn<sub>6</sub>-CO<sub>1</sub> (<italic>&#x3b4;</italic>
<sub>C</sub> 170.3), and from Avi<sub>8</sub>-NH (<italic>&#x3b4;</italic>
<sub>H</sub> 8.95) to Gly<sub>7</sub>-CO (<italic>&#x3b4;</italic>
<sub>C</sub> 167.6), suggesting that nine units were connected to yield a sequence of MGFA-Ala<sub>1</sub>-Avi<sub>2</sub>-Val<sub>3</sub>-Ser<sub>4</sub>-Avi<sub>5</sub>-Asp<sub>6</sub>/Asn<sub>6</sub>-Gly<sub>7</sub>-Avi<sub>8</sub>. The two DBEs were accounted for realizing the dicyclic structure of <bold>1</bold>. The key HMBC correlations from Avi<sub>2</sub>-3 (<italic>&#x3b4;</italic>
<sub>H</sub> 3.01, 2.11) to Avi<sub>5</sub>-2 (<italic>&#x3b4;</italic>
<sub>C</sub> 60.9) established the connectivity of Avi<sub>2</sub> and Avi<sub>5</sub>. Additionally, considering the chemical shift of Avi<sub>8</sub>-1 (<italic>&#x3b4;</italic>
<sub>C</sub> 98.7) and Avi<sub>5</sub>-3 (<italic>&#x3b4;</italic>
<sub>C</sub> 41.0), and the requirement of unsaturation, the connection of (Avi<sub>5</sub>-3)-S-(Avi<sub>8</sub>-1) was deduced as found in nocavionin and microvionin (<xref ref-type="bibr" rid="B21">Wiebach et al., 2018</xref>). Based on the combination of previous information and the molecular formula, one Asp unit was assigned in <bold>1</bold>. Thus, the planar structure of <bold>1</bold> was determined, as shown in <xref ref-type="fig" rid="F1">Figure 1</xref>. Notably, <bold>1</bold> contains an odd number of nitrogen atoms and an even number of hydrogen atoms, which suggests that the MGFA unit with the positively charged functional group is found in goadvionins (<xref ref-type="bibr" rid="B12">Kozakai et al., 2020</xref>).</p>
<p>The configurations of the amino acid residues in <bold>1</bold> were further determined by the advanced Marfey&#x2019;s method. The acid hydrolysates of <bold>1</bold> were derivatized with <italic>L</italic>-FDAA and <italic>D</italic>-FDAA. By comparing the retention times with standards (<xref ref-type="sec" rid="s10">Supplementary Figures S5&#x2013;S8</xref>; <xref ref-type="sec" rid="s10">Supplementary Table S1</xref>), the absolute configurations of Ala<sub>1</sub>, Val<sub>3</sub>, Ser<sub>4</sub>, and Asp<sub>6</sub> were all established as <italic>S</italic>-configurations, leaving two chiralities in Avi<sub>2</sub> and Avi<sub>5</sub> residues to be clarified.</p>
<p>The remaining two configurations in Avi<sub>2</sub> and Avi<sub>5</sub> are proving to be a challenge to resolve. However, unlike the NMR spectra of nocavionin and microvionin in D<sub>2</sub>O and H<sub>2</sub>O, respectively, which showed the presence of conformer isomers (<xref ref-type="bibr" rid="B21">Wiebach et al., 2018</xref>), the NMR spectra of nocaviogua A (<bold>1</bold>) in DMSO-<italic>d</italic>
<sub>6</sub> did not exhibit any obvious signals indicating different conformers. This allows us to use the GIAO NMR calculation to determine their stereochemistry. In order to solve the structure of complex, large, and highly flexible molecules using readily available computational resources, the MGFA was replaced with acetic acid and the four possible diastereomers <bold>1a</bold>&#x2013;<bold>1d</bold> (<xref ref-type="fig" rid="F2">Figure 2</xref>) were evaluated. Conformational searches were performed at OpenBabel with the MMFF94 force field and an energy cutoff value of 3.00&#xa0;kcal/mol. Subsequently, the obtained conformers were optimized by the DFT method at the M062X/6-311&#x2b;G (d, p) level in vacuum, and the NMR chemical shifts were calculated at the PCM/mPW1PW91/6-311&#x2b;G (d, p) level. Accordingly, the calculated carbon chemical shifts for <bold>1a</bold> showed the highest similarity toward the experimental values with the smallest corrected mean absolute error (CMAE, <bold>1a</bold>: 1.5113 vs. <bold>1b</bold>&#x2013;<bold>1d</bold>: 2.0405, 1.9820, and 1.8977 in <sup>13</sup>C NMR data and <bold>1a</bold>: 0.1397 vs. <bold>1b</bold>&#x2013;<bold>1d</bold>: 0.2068, 0.1813, and 0.2073 in <sup>1</sup>H NMR data, respectively) values (<xref ref-type="sec" rid="s10">Supplementary Tables S2&#x2013;S3</xref>), particularly for Avi<sub>2</sub> and Avi<sub>5</sub> moieties (<xref ref-type="fig" rid="F3">Figure 3</xref>). In addition, DP4&#x2b; analysis based on NMR data provided 100% probability for the isomer <bold>1a</bold> (<xref ref-type="sec" rid="s10">Supplementary Table S4</xref>), indicative of the <italic>S</italic>, <italic>S</italic> configuration for Avi<sub>2</sub> and Avi<sub>5</sub> moieties in <bold>1</bold>. Thus, the whole structure of compound <bold>1</bold> was fully determined and designated as nocaviogua A (<bold>1</bold>).</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>Four possible diastereomers (<bold>1a</bold>&#x2013;<bold>1d</bold>).</p>
</caption>
<graphic xlink:href="fchem-11-1233938-g002.tif"/>
</fig>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>Corrected absolute errors of <sup>13</sup>C chemical shifts in the Avi<sub>2</sub> and Avi<sub>5</sub> units calculated for <bold>1a</bold>&#x2013;<bold>1d</bold>.</p>
</caption>
<graphic xlink:href="fchem-11-1233938-g003.tif"/>
</fig>
<p>Nocaviogua B (<bold>2</bold>), white powder, was determined as C<sub>41</sub>H<sub>66</sub>N<sub>12</sub>O<sub>11</sub>S, based on the HRESIMS peak at <italic>m/z</italic> 935.4766 [M &#x2b; H]<sup>&#x2b;</sup> (calcd for C<sub>41</sub>H<sub>67</sub>N<sub>12</sub>O<sub>11</sub>S, 935.4773), implying 15 DBEs. The <sup>1</sup>H NMR and <sup>13</sup>C NMR data (<xref ref-type="table" rid="T1">Table 1</xref>) for <bold>2</bold> that were recorded in DMSO-<italic>d</italic>
<sub>
<italic>6</italic>
</sub> revealed nine amide and/or ester carbonyl carbons (<italic>&#x3b4;</italic>
<sub>C</sub> 165.5&#x2013;172.7) and nine alkenyl carbons (<italic>&#x3b4;</italic>
<sub>C</sub> 99.3&#x2013;158.3 and <italic>&#x3b4;</italic>
<sub>H</sub> 7.19&#x2013;5.38), accounting for 14 DBEs and requiring only one ring incorporation into <bold>2</bold>. The <sup>1</sup>H and <sup>13</sup>C NMR (DMSO-<italic>d</italic>
<sub>6</sub>) data for <bold>2</bold> were closely similar to those with <bold>1</bold> except for three signals of NH (Asn<sub>6</sub>-4-NH<sub>2</sub>: <italic>&#x3b4;</italic>
<sub>H</sub> 7.33 and 6.89 and Ser<sub>4</sub>-NH<sub>2</sub>: <italic>&#x3b4;</italic>
<sub>H</sub> 8.11) in <bold>2,</bold> which is more than <bold>1</bold>, indicating that the amide bond between Val<sub>3</sub> and Ser<sub>4</sub> was opened, and the Asp unit in <bold>1</bold> was replaced with the Asn residue in <bold>2</bold>. This hypothesis was further confirmed by HMBC and <sup>1</sup>H-<sup>1</sup>H COSY correlations (<xref ref-type="fig" rid="F1">Figure 1</xref>). Based on the coupling constant and the ROESY correlation, the geometry of the double bond in the Avi<sub>8</sub> moiety was established as <italic>Z</italic> and the alkenyls in MGFA were all in the <italic>E</italic> arrangement, which were the same as in <bold>1</bold>. Considering the number of nitrogen atoms and hydrogen atoms, the MGFA unit in <bold>2</bold> was also with the positively charged functional group as in <bold>1</bold>.</p>
<p>The absolute configurations of Ala, Val, Ser, and Asn moieties were determined as <italic>L</italic> by the advanced Marfey&#x2019;s method (<xref ref-type="sec" rid="s10">Supplementary Figures S11&#x2013;S14</xref>; <xref ref-type="sec" rid="s10">Supplementary Table S1</xref>). The configurations in Avi<sub>2</sub> and Avi<sub>5</sub> units of compound <bold>2</bold> were also determined using GIAO NMR calculations by evaluating the four possible diastereomers <bold>2a</bold>&#x2013;<bold>2d</bold> (<xref ref-type="sec" rid="s10">Supplementary Figure S27</xref>). Consequently, the calculated carbon chemical shifts of <bold>2a</bold> showed the highest probability to the experimental values with the smallest CMAE (<bold>2a</bold>: 1.4284 vs. <bold>2b</bold>&#x2013;<bold>2d</bold>: 1.6495, 1.8486, and 1.6907 in <sup>13</sup>C NMR data and <bold>2a</bold>: 0.2186 vs. <bold>2b</bold>&#x2013;<bold>2d</bold>: 0.2303, 0.2732, and 0.2248 in <sup>1</sup>H NMR data, respectively) values (<xref ref-type="sec" rid="s10">Supplementary Tables S13&#x2013;S14</xref>). In addition, DP4&#x2b; analysis based on NMR data with 100% probability for the isomer <bold>2a</bold> (<xref ref-type="sec" rid="s10">Supplementary Table S15</xref>), assigned Avi<sub>2</sub> and Avi<sub>5</sub> units as <italic>S</italic>, <italic>S</italic> configurations, respectively, are identical to those determined in compound <bold>1</bold>. Thus, the whole structure of compound <bold>2</bold> was fully determined and designated as nocaviogua B (<bold>2</bold>).</p>
</sec>
<sec id="s3-2">
<title>3.2 Antibacterial assays</title>
<p>The two compounds were evaluated for their antibacterial activity on <italic>Candida albicans</italic> (ATCC 10231), <italic>Staphylococcus aureus</italic> (ATCC 29213), <italic>Enterococcus faecium</italic> (ATCC 35667), <italic>Candida tropicalis</italic> (ATCC 1369), <italic>Escherichia coli</italic> (ATCC 25922), <italic>Klebsiella pneumoniae</italic> (ATCC 700603), and <italic>Pseudomonas aeruginosa</italic> (ATCC 27853) by MIC values. Regrettably, both compounds <bold>1</bold> and <bold>2</bold> showed no antibacterial effect at concentrations up to 128&#xa0;<italic>&#x3bc;</italic>g/mL.</p>
</sec>
<sec id="s3-3">
<title>3.3 Cytotoxic activity assays</title>
<p>The cytotoxicity of compounds <bold>1</bold>-<bold>2</bold> was assayed against uveal melanoma cells (UM92-1), non-small cell lung cancer (NCI-H2170), and three breast cancer cell lines (SK-BR-3, MDA-MB-231, and MDA-MB-453). Compound <bold>1</bold> exhibited weak cytotoxicity against UM92-1, NCI-H2170, and MDA-MB-231, exhibiting an inhibition rate of approximately 15%, 30.0%, and 31.1%, respectively, at a concentration of 50&#xa0;<italic>&#x3bc;</italic>M (<xref ref-type="fig" rid="F4">Figure 4</xref>). Compound <bold>2</bold> shows no obvious cytotoxic activity at the same concentration.</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>Cytotoxicity of <bold>1</bold> and <bold>2,</bold> and bleomycin against five types of cancer cell lines at 50&#xa0;<italic>&#x3bc;</italic>M.</p>
</caption>
<graphic xlink:href="fchem-11-1233938-g004.tif"/>
</fig>
</sec>
</sec>
<sec sec-type="conclusion" id="s4">
<title>4 Conclusion</title>
<p>Lipolanthines, featuring unique structures and physicochemical properties, are increasingly attracting wide interests as pharmaceutical leads (<xref ref-type="bibr" rid="B8">Grant-Mackie et al., 2021</xref>). In our research, two new lipolanthines, nocaviogua A (<bold>1</bold>) and B (<bold>2</bold>), were identified from mutualistic actinomycete <italic>Nocardia</italic> sp. XZ19_369 that was isolated from the nodules of sea buckthorn collected in Tibet. Their planar structures were elucidated via extensive 1D and 2D NMR, and HRMS data. The absolute configurations were fully elucidated by advanced Marfey&#x2019;s analysis and GIAO NMR calculations.</p>
<p>Structurally, compounds <bold>1</bold> and <bold>2</bold> are analogs of microvionin, nocavionin, and goadvionins. Unlike their analogs, compounds <bold>1</bold> and <bold>2</bold> did not exhibit any antimicrobial activity against the seven tested pathogens at concentrations up to 128&#xa0;<italic>&#x3bc;</italic>g/mL. However, compound <bold>1</bold> did show weak cytotoxicity against cancer cell lines UM92-1, NCI-H2170, and MDA-MB-231, with inhibition rates of approximately 15%, 30.0%, and 31.1%, respectively, at a concentration of 50&#xa0;<italic>&#x3bc;</italic>M. On the other hand, compound <bold>2</bold>, the one-ring-opened derivative of compound <bold>1</bold>, did not show any obvious cytotoxic activity, suggesting that the bicycle scaffold in lipolanthines plays a crucial role in their cytotoxicity. To date, 12 lipolanthines have been discovered, but nocaviogua A (<bold>1</bold>) and B (<bold>2</bold>) were the first compounds in this family with fully determined configurations, which is of great importance for further stereoselective synthesis and bioactive studies.</p>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="s5">
<title>Data availability statement</title>
<p>The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found in the article/<xref ref-type="sec" rid="s10">Supplementary Material</xref>.</p>
</sec>
<sec id="s6">
<title>Author contributions</title>
<p>Conceptualization: YX and LY; methodology: SC; software: YX; validation: YX and SC; formal analysis: SC and YX; investigation: SC; resources: YL, MC, and NH; data curation: SC and XH; writing&#x2014;original draft preparation: SC; writing&#x2014;review and editing: YX and SC; visualization: YX; supervision: YX and LY; project administration: YX; funding acquisition: YX, LY, and SC. All authors contributed to the article and approved the submitted version.</p>
</sec>
<sec id="s7">
<title>Funding</title>
<p>This work was financially supported by the Program for The National Natural Science Foundation of China (grant nos 81973219 and 82104047), the CAMS Innovation Fund for Medical Sciences (CIFMS, 2021-I2M-1-028), and the National Science Foundation of Hebei Province (grant no. H2021209027).</p>
</sec>
<sec sec-type="COI-statement" id="s8">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s9">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors, and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s10">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fchem.2023.1233938/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fchem.2023.1233938/full&#x23;supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="DataSheet1.docx" id="SM1" mimetype="application/docx" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alanjary</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Steinke</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Ziemert</surname>
<given-names>N.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>AutoMLST: An automated web server for generating multi-locus species trees highlighting natural product potential</article-title>. <source>Nucleic Acids Res.</source> <volume>47</volume> (<issue>W1</issue>), <fpage>W276</fpage>&#x2013;<lpage>W282</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkz282</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bobeica</surname>
<given-names>S. C.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Acedo</surname>
<given-names>J. Z.</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>van der Donk</surname>
<given-names>W. A.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Structural determinants of macrocyclization in substrate-controlled lanthipeptide biosynthetic pathways</article-title>. <source>Chem. Sci.</source> <volume>11</volume> (<issue>47</issue>), <fpage>12854</fpage>&#x2013;<lpage>12870</lpage>. <pub-id pub-id-type="doi">10.1039/d0sc01651a</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>2022a</year>). <article-title>Prenylemestrins A and B: Two unexpected epipolythiodioxopiperazines with a thioethanothio bridge from emericella sp. isolated by genomic analysis</article-title>. <source>Org. Lett.</source> <volume>24</volume> (<issue>32</issue>), <fpage>5941</fpage>&#x2013;<lpage>5945</lpage>. <pub-id pub-id-type="doi">10.1021/acs.orglett.2c02187</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2022b</year>). <article-title>Cytotoxic hexadepsipeptides and anti-coronaviral 4-hydroxy-2-pyridones from an endophytic Fusarium sp</article-title>. <source>Front. Chem.</source> <volume>10</volume>, <fpage>1106869</fpage>. <pub-id pub-id-type="doi">10.3389/fchem.2022.1106869</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Cockerill</surname>
<given-names>F. W. M.</given-names>
</name>
<name>
<surname>Alder</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Dudley</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Eliopoulos</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Ferraro</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2012</year>). <source>Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: Approved standard</source>.</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Daranas</surname>
<given-names>A. H.</given-names>
</name>
<name>
<surname>Sarotti</surname>
<given-names>A. M.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Are computational methods useful for structure elucidation of large and flexible molecules? Belizentrin as a case study</article-title>. <source>Org. Lett.</source> <volume>23</volume> (<issue>2</issue>), <fpage>503</fpage>&#x2013;<lpage>507</lpage>. <pub-id pub-id-type="doi">10.1021/acs.orglett.0c04016</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Frisch</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Schlegel</surname>
<given-names>H. B.</given-names>
</name>
<name>
<surname>Scuseria</surname>
<given-names>G. E.</given-names>
</name>
<name>
<surname>Robb</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Cheeseman</surname>
<given-names>J. R.</given-names>
</name>
<etal/>
</person-group> (<year>2010</year>). &#x201c;<article-title>Gaussian 09</article-title>,&#x201d; in <source>Revision C.01</source> (<publisher-loc>Wallingford CT</publisher-loc>: <publisher-name>Gaussian, Inc.</publisher-name>).</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grant-Mackie</surname>
<given-names>E. S.</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>E. T.</given-names>
</name>
<name>
<surname>Harris</surname>
<given-names>P. W. R.</given-names>
</name>
<name>
<surname>Brimble</surname>
<given-names>M. A.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Aminovinyl cysteine containing peptides: A unique motif that imparts key biological activity</article-title>. <source>JACS Au</source> <volume>1</volume> (<issue>10</issue>), <fpage>1527</fpage>&#x2013;<lpage>1540</lpage>. <pub-id pub-id-type="doi">10.1021/jacsau.1c00308</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grimblat</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Zanardi</surname>
<given-names>M. M.</given-names>
</name>
<name>
<surname>Sarotti</surname>
<given-names>A. M.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Beyond DP4: An improved probability for the stereochemical assignment of isomeric compounds using quantum chemical calculations of NMR shifts</article-title>. <source>J. Org. Chem.</source> <volume>80</volume> (<issue>24</issue>), <fpage>12526</fpage>&#x2013;<lpage>12534</lpage>. <pub-id pub-id-type="doi">10.1021/acs.joc.5b02396</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kiyonaga Fujii</surname>
<given-names>Y. I.</given-names>
</name>
<name>
<surname>Mayumi</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Oka</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Suzuki</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ken-ichi</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>1997b</year>). <article-title>A nonempirical method using LC/MS for determination of the absolute configuration of constituent amino acids in a Peptide: combination of marfey&#x27;s method with mass spectrometry and its practical application</article-title>. <source>Anal. Chem.</source> <volume>69</volume>, <fpage>5146</fpage>&#x2013;<lpage>5151</lpage>. <pub-id pub-id-type="doi">10.1021/ac970289b</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kiyonaga Fujii</surname>
<given-names>Y. I.</given-names>
</name>
<name>
<surname>Oka</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Suzuki</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Harada</surname>
<given-names>K. i.</given-names>
</name>
<name>
<surname>Suzuki</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Harada</surname>
<given-names>K. i.</given-names>
</name>
</person-group> (<year>1997a</year>). <article-title>A nonempirical method using LC/MS for determination of the absolute configuration of constituent amino acids in a Peptide: elucidation of limitations of marfey&#x27;s method and of its separation mechanism</article-title>. <source>Anal. Chem.</source> <volume>69</volume> (<issue>16</issue>), <fpage>3346</fpage>&#x2013;<lpage>3352</lpage>. <pub-id pub-id-type="doi">10.1021/ac9701795</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kozakai</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Ono</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Hoshino</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Takahashi</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Katsuyama</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Sugai</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Acyltransferase that catalyses the condensation of polyketide and peptide moieties of goadvionin hybrid lipopeptides</article-title>. <source>Nat. Chem.</source> <volume>12</volume> (<issue>9</issue>), <fpage>869</fpage>&#x2013;<lpage>877</lpage>. <pub-id pub-id-type="doi">10.1038/s41557-020-0508-2</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Luo</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Xi</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>N.</given-names>
</name>
<etal/>
</person-group> (<year>2022a</year>). <article-title>Molecular networking-based screening led to the discovery of a cyclic heptadepsipeptide from an endolichenic xylaria sp</article-title>. <source>J. Nat. Prod.</source> <volume>85</volume> (<issue>4</issue>), <fpage>972</fpage>&#x2013;<lpage>979</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jnatprod.1c01108</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Luo</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Shan</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2022b</year>). <article-title>Halogenase-targeted genome mining leads to the discovery of (&#xb1;) pestalachlorides A1a, A2a, and their atropisomers</article-title>. <source>Antibiot. (Basel)</source> <volume>11</volume> (<issue>10</issue>), <fpage>1304</fpage>. <pub-id pub-id-type="doi">10.3390/antibiotics11101304</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mazo</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Rahman</surname>
<given-names>I. R.</given-names>
</name>
<name>
<surname>Navo</surname>
<given-names>C. D.</given-names>
</name>
<name>
<surname>Peregrina</surname>
<given-names>J. M.</given-names>
</name>
<name>
<surname>Busto</surname>
<given-names>J. H.</given-names>
</name>
<name>
<surname>van der Donk</surname>
<given-names>W. A.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Synthesis of fluorescent lanthipeptide cytolysin S analogues by late-stage sulfamidate ring opening</article-title>. <source>Org. Lett.</source> <volume>25</volume> (<issue>9</issue>), <fpage>1431</fpage>&#x2013;<lpage>1435</lpage>. <pub-id pub-id-type="doi">10.1021/acs.orglett.3c00122</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Montalban-Lopez</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Scott</surname>
<given-names>T. A.</given-names>
</name>
<name>
<surname>Ramesh</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Rahman</surname>
<given-names>I. R.</given-names>
</name>
<name>
<surname>van Heel</surname>
<given-names>A. J.</given-names>
</name>
<name>
<surname>Viel</surname>
<given-names>J. H.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>New developments in RiPP discovery, enzymology and engineering</article-title>. <source>Nat. Prod. Rep.</source> <volume>38</volume> (<issue>1</issue>), <fpage>130</fpage>&#x2013;<lpage>239</lpage>. <pub-id pub-id-type="doi">10.1039/d0np00027b</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>O&#x27;Boyle</surname>
<given-names>N. M.</given-names>
</name>
<name>
<surname>Banck</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>James</surname>
<given-names>C. A.</given-names>
</name>
<name>
<surname>Morley</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Vandermeersch</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Hutchison</surname>
<given-names>G. R.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Open Babel: An open chemical toolbox</article-title>. <source>J. Cheminform</source> <volume>3</volume>, <fpage>33</fpage>. <pub-id pub-id-type="doi">10.1186/1758-2946-3-33</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ongey</surname>
<given-names>E. L.</given-names>
</name>
<name>
<surname>Yassi</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Pflugmacher</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Neubauer</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Pharmacological and pharmacokinetic properties of lanthipeptides undergoing clinical studies</article-title>. <source>Biotechnol. Lett.</source> <volume>39</volume> (<issue>4</issue>), <fpage>473</fpage>&#x2013;<lpage>482</lpage>. <pub-id pub-id-type="doi">10.1007/s10529-016-2279-9</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="book">
<collab>Spartan14. Wavefunction</collab> (<year>2019</year>). <source>Spartan&#x2019;14 for windows,macintosh and linux</source>. <publisher-loc>Irvine, CA</publisher-loc>: <publisher-name>WAVEFUNCTION, INC</publisher-name>.</citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Watrous</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Roach</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Alexandrov</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Heath</surname>
<given-names>B. S.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>J. Y.</given-names>
</name>
<name>
<surname>Kersten</surname>
<given-names>R. D.</given-names>
</name>
<etal/>
</person-group> (<year>2012</year>). <article-title>Mass spectral molecular networking of living microbial colonies</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source> <volume>109</volume> (<issue>26</issue>), <fpage>E1743</fpage>&#x2013;<lpage>E1752</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1203689109</pub-id>
</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wiebach</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Mainz</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Siegert</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Jungmann</surname>
<given-names>N. A.</given-names>
</name>
<name>
<surname>Lesquame</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Tirat</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>The anti-staphylococcal lipolanthines are ribosomally synthesized lipopeptides</article-title>. <source>Nat. Chem. Biol.</source> <volume>14</volume> (<issue>7</issue>), <fpage>652</fpage>&#x2013;<lpage>654</lpage>. <pub-id pub-id-type="doi">10.1038/s41589-018-0068-6</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>